# A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)

> **NCT02015156** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 162 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-05280014
- **BIOLOGICAL:** Herceptin®

## Key facts

- **NCT ID:** NCT02015156
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-04
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2014-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015156, "A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02015156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*